What is the appropriate evaluation and management of vomiting in a reproductive‑age woman following a dilation and curettage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup and Management of Vomiting After Dilation and Curettage

Immediately assess hydration status and administer intravenous fluids to maintain adequate perfusion, then treat with ondansetron 4-8 mg IV as first-line antiemetic therapy. 1, 2, 3

Initial Assessment and Stabilization

Hydration Status Evaluation

  • Check vital signs for orthostatic hypotension (blood pressure drop >20 mmHg systolic or >10 mmHg diastolic when standing), tachycardia, and signs of dehydration including dry mucous membranes, decreased skin turgor, and reduced urine output. 1
  • Initiate IV crystalloid resuscitation immediately if dehydration is present, as adequate hydration reduces nausea independent of antiemetic drugs and is critical after procedures with potential blood loss. 1, 3
  • Target fluid administration of ≥1.5 L/day to maintain adequate hydration, with increased requirements if vomiting persists. 1

Timing and Severity Assessment

  • Determine whether vomiting began intraoperatively (suggesting anesthesia-related causes) or postoperatively (suggesting surgical complications or medication effects). 1
  • Assess frequency and volume of vomiting episodes, as persistent vomiting >2-3 weeks requires thiamin supplementation to prevent neurological complications. 1

First-Line Antiemetic Therapy

Ondansetron Administration

  • Administer ondansetron 4-8 mg IV over 2-5 minutes as initial treatment for established postoperative nausea and vomiting. 2, 3, 4
  • Use 8 mg dosing for moderate-to-severe symptoms, with repeat dosing every 12 hours as needed, maximum 16 mg/day. 2, 4
  • Monitor QT interval in patients with cardiac risk factors, electrolyte abnormalities, or concurrent QT-prolonging medications. 2, 3, 4

Supportive Measures

  • Prescribe stool softeners prophylactically when ondansetron is used, as constipation worsens with cumulative exposure and dehydration. 2, 3
  • Encourage oral fluid intake once tolerated, avoiding carbonated and sugar-sweetened beverages. 1

Rescue Therapy for Persistent Vomiting

Second-Line: Dopamine Antagonists

  • If nausea persists 30-60 minutes after ondansetron, switch to metoclopramide 10 mg IV (administered slowly over 1-2 minutes) rather than repeating ondansetron, as using the same drug class for rescue reduces effectiveness. 2, 3, 4
  • Alternative dopamine antagonists include prochlorperazine 5-10 mg IV/PO every 6 hours or haloperidol 0.5-2 mg IV/PO every 4-6 hours when metoclopramide is contraindicated. 2, 3, 4
  • Monitor for extrapyramidal symptoms with dopamine antagonists, especially at higher doses; low-dose haloperidol (0.5-2 mg) has minimal risk. 2

Third-Line: Add Corticosteroid

  • Add dexamethasone 4 mg IV for refractory nausea that persists after ondansetron plus a dopamine antagonist. 2, 3, 4
  • This dose provides effective antiemetic benefit without additional advantage from higher doses and avoids excess hyperglycemia risk. 3

Multimodal Approach for Severe Cases

  • For intractable vomiting, continue the dopamine antagonist, add dexamethasone 4 mg IV (if not already given), and consider lorazepam 0.5-2 mg IV/PO every 6 hours for anticipatory or anxiety-related nausea. 2, 3
  • Consider scopolamine transdermal patch (1.5-3 mg over 72 hours) if oral secretions are problematic. 2, 3

Evaluation for Surgical Complications

Red Flags Requiring Urgent Investigation

  • Refractory vomiting despite compliance with nutritional recommendations and multimodal antiemetic therapy may indicate surgical complications including retained products of conception, uterine perforation, bowel injury, or infection. 1
  • Assess for fever, severe abdominal pain, peritoneal signs, or abnormal vaginal bleeding/discharge that would suggest endometritis, perforation, or other complications. 1
  • Bilious vomiting or abdominal distension suggests possible bowel obstruction from unrecognized bowel injury during the procedure. 1

Laboratory and Imaging Considerations

  • Check complete blood count if significant bleeding is suspected, and metabolic panel to assess electrolyte abnormalities from persistent vomiting. 1
  • Consider pelvic ultrasound if retained products of conception are suspected or if clinical examination is concerning for uterine perforation. 1
  • Obtain surgical consultation immediately if peritoneal signs, severe pain, or hemodynamic instability are present. 1

Nutritional Management

Early Oral Intake

  • Resume regular diet within 2 hours after D&C once patient is alert and hemodynamically stable, as early feeding improves recovery without increasing complications. 1
  • If vomiting prevents oral intake, maintain IV hydration and reassess tolerance every 2-4 hours. 1

Eating Behavior Modifications

  • Instruct patient to eat slowly, chew thoroughly (≥15 chews per bite), and consume small quantities at each meal to prevent regurgitation. 1
  • Avoid dry foods and encourage consumption of easily digestible options if nausea persists. 1

Prevention of Complications

Thiamin Supplementation

  • Initiate thiamin supplementation if vomiting persists for >2-3 weeks to prevent Wernicke encephalopathy and other neurological complications. 1

Opioid Minimization

  • Limit postoperative opioid use as opioids are a strong predictor of postoperative nausea; substitute oral acetaminophen or NSAIDs for pain control. 3
  • Use multimodal analgesia including regular NSAIDs and paracetamol to reduce opioid requirements. 1

Common Pitfalls to Avoid

  • Do not repeat ondansetron dosing beyond 16 mg/day or use scheduled three-times-daily dosing, as this increases QT prolongation risk without additional benefit. 2, 4
  • Do not use ondansetron as monotherapy for rescue if the patient received ondansetron prophylactically during surgery; switch to a different antiemetic class. 2, 3, 4
  • Do not delay evaluation for surgical complications if vomiting is severe, persistent, or accompanied by fever, severe pain, or peritoneal signs. 1
  • Do not assume all postoperative vomiting is benign; maintain high index of suspicion for uterine perforation or bowel injury, especially if vomiting is bilious or associated with abdominal distension. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ondansetron Dosing and Administration for Post-Operative Nausea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Postoperative Nausea after Spinal Anesthesia for Open Appendectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ondansetron for Post-Cesarean Section Nausea and Vomiting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.